IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 41 - 60 of 1246 stories.
February 3, 2015
Galmed and Perrigo sign API manufacturing deal Galmed Pharmaceuticals (Tel Aviv), a company focused on developing and commercializing a once-daily, oral medication to treat liver...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-3-February-2015_67443.html
February 2, 2015
Amyris (Emeryville, CA) says it plans to offer its synthetic biology discovery and production platform to pharmaceutical makers. Amyris says it will offer an integrated discovery and...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Amyris-to-launch-biopharma-platform_67410.html
February 1, 2015
The FTC on Friday cleared Sun Pharmaceutical’s $4 billion proposed acquisition of Ranbaxy Laboratories on condition that the companies divest Ranbaxy’s interests in generic...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/FTC-clears-Sun-Pharmas-acquisition-of-Ranbaxy-on-condition-that-they-divest-a-business_67385.html
January 29, 2015
Ash Stevens (Riverview, MI), a provider of global contract pharmaceutical drug substance development and active pharmaceutical ingredient (API) manufacturing services, says that FDA...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Ash-Stevens-to-manufacture-amotosalen-API-for-Cerus_67310.html
January 29, 2015
Galmed Pharmaceuticals (Tel Aviv), a company focused on developing and commercializing a once-daily, oral medication to treat liver diseases and cholesterol gallstones, says that it...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Galmed-and-Perrigo-sign-API-manufacturing-deal_67309.html
January 29, 2015
The European Commission said on Wednesday that it has cleared both GlaxoSmithKline's (GSK) proposed acquisition of Novartis's vaccines business and the proposed creation of...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/EU-conditionally-approves-GSK-Novartis-deals_67307.html
January 29, 2015
Umicore (Brussels) says that its precious metals chemistry business unit has appointed a subsidiary of Midas Pharma (Ingelheim, Germany) at Parsippany, NJ, as the exclusive sales agent...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Umicores-API-business-appoints-sales-partner-for-North-America_67298.html
January 27, 2015
Feature Fine chemicals: Stringent regulations prompt return of manufacturing to the West Pharmaceutical ingredient manufacturers are witnessing a rise in demand, and they remain...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-27-January-2015_67232.html
January 26, 2015
MGC Pharma (Tokyo), a wholly owned subsidiary of Mitsubishi Gas Chemical (MGC); and Catalent Pharma Solutions (Somerset, NJ), a leading contract manufacturer of pharmaceuticals, have...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Mitsubishi-Gas-Chemical-subsidiary-and-Catalent-sign-deal-for-biosimilars_67193.html
January 23, 2015
FDA, on 22 January, issued an import alert for an active pharmaceutical ingredient (API) manufacturing facility of Ipca Laboratories (Mumbai), located at Ratlam, India. An import alert...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/FDA-issues-import-alert-against-Ipca-API-plant_67168.html
January 20, 2015
AMRI receives NIH contract for drug development and manufacturing services Albany Molecular Research Inc. (AMRI; Albany) says that it has received a 10-year federal contract award from...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-20-January-2015_66991.html
January 19, 2015
Albany Molecular Research Inc. (AMRI; Albany) says that it has received a 10-year federal contract award from the National Institutes of Health (NIH; Bethesda, MD) for drug development...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/AMRI-receives-NIH-contract-for-drug-development-and-manufacturing-services_66967.html
January 14, 2015
Shire (Dublin) and NPS Pharmaceuticals (Bedminster, NJ) today announced that they have entered into an agreement for Shire to acquire all the outstanding shares of NPS Pharma for...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Shire-to-acquire-NPS-Pharma-for-$5-2-billion-building-leading-biotech-position_66731.html
January 13, 2015
Active pharmaceutical ingredients (APIs) producer Hovione (Loures, Portugal) says that it has appointed Filipe Gaspar as v.p./R&D. Gaspar will lead the teams based at Lisbon and...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Hovione-appoints-head-of-R-and-D_66772.html
January 13, 2015
AMRI to acquire Aptuit’s drug product development and aseptic clinical manufacturing businesses Albany Molecular Research Inc. (AMRI; Albany, NY) says that it has acquired...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-13-January-2015_66781.html
January 6, 2015
FDA issues warning letter to API plant in China FDA issued a warning letter on 19 December to the active pharmaceutical ingredient (API) and finished pharmaceutical manufacturing...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-6-January-2015_66577.html
January 5, 2015
The number of new drugs approved by FDA last year rose to 41 from 27 in 2013, the highest number for 18 years. The 2014 approval list included 15 drugs for so-called orphan...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/FDA-new-drug-approvals-rise-to-18-year-high_66541.html
January 5, 2015
Novartis has announced it completed, on 1 January, divesting its animal health division to Eli Lilly for approximately $5.40 billion. The deal is part of a comprehensive set of...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Novartis-completes-divestment-of-animal-health-business-to-Eli-Lilly-for-$5-4-billion_66540.html
January 5, 2015
SRF (Gurgaon), a leading Indian manufacturer of hydrofluorocarbon (HFC) refrigerants, has acquired the global HFC-134a pharmaceutical propellant gases business of DuPont for $20...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Indian-firm-acquires-DuPonts-Dymel-pharma-grade-HFC-134a-business_66538.html
December 31, 2014
FDA issued a warning letter on 19 December to the active pharmaceutical ingredient (API) and finished pharmaceutical manufacturing facilities of Novacyl Wuxi Pharmaceutical...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/FDA-issues-warning-letter-to-API-plant-in-China_66511.html
Pages: « Previous  1 2 [3] 4 5 6 7 8 9 10 11 12 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa